Cost-effectiveness of FDG-PET in staging non-small cell lung cancer: the PLUS study

This publication has 16 references indexed in Scilit:

• The impact of fluorodeoxyglucose F 18 positron-emission tomography on the surgical staging of non–small cell lung cancer
  The Journal of Thoracic and Cardiovascular Surgery, 2002
• Solitary pulmonary nodules: accuracy and cost-effectiveness of sodium iodide FDG-PET using Australian data
  European Journal of Nuclear Medicine and Molecular Imaging, 2002
• Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: the PLUS multicentre randomised trial
  The Lancet, 2002
• A Cost Analysis of Positron Emission Tomography
  American Journal of Roentgenology, 2001
• [Lung cancer in the Netherlands in the period 1989-1997: the epidemic is not over yet].
  2001
• Toward Less Futile Surgery in Non-Small Cell Lung Cancer? A Randomized Clinical Trial to Evaluate the Cost-Effectiveness of Positron Emission Tomography
  Controlled Clinical Trials, 2001
• Cost-effectiveness of FDG-PET for the management of solitary pulmonary nodules: a decision analysis based on cost reimbursement in Germany.
  European Journal of Nuclear Medicine and Molecular Imaging, 2000
• Preoperative Staging of Non–Small-Cell Lung Cancer with Positron-Emission Tomography
  New England Journal of Medicine, 2000
• Costs of F-18-FDG PET: Experience with a satellite concept
  Nuklearmedizin-Nuclear Medicine, 1998
• Decision tree sensitivity analysis for cost-effectiveness of FDG-PET in the staging and management of non-small-cell lung carcinoma.
  1996